Next Article in Journal
Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections
Next Article in Special Issue
Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective
Previous Article in Journal
Dose–Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An “All-in-One” Multicenter–Multidisciplinary Practical Summary
Previous Article in Special Issue
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center
 
 
Article

Article Versions Notes

Curr. Oncol. 2022, 29(10), 7051-7058; https://doi.org/10.3390/curroncol29100553
Action Date Notes Link
article xml file uploaded 28 September 2022 08:43 CEST Original file -
article xml uploaded. 28 September 2022 08:43 CEST Update https://www.mdpi.com/1718-7729/29/10/553/xml
article pdf uploaded. 28 September 2022 08:43 CEST Version of Record https://www.mdpi.com/1718-7729/29/10/553/pdf
article html file updated 28 September 2022 08:45 CEST Original file https://www.mdpi.com/1718-7729/29/10/553/html
Back to TopTop